Genenta Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . Genenta Science SpA
GNTA Stock  USD 4.78  0.01  0.21%   
Genenta Science financial statements provide useful quarterly and yearly information to potential Genenta Science SpA investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Genenta Science financial statements helps investors assess Genenta Science's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Genenta Science's valuation are summarized below:
Market Capitalization
87.6 M
Earnings Share
(0.51)
We have found one hundred nineteen available fundamental trends for Genenta Science SpA, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to confirm all of Genenta Science SpA regular market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road. The current year's Market Cap is expected to grow to about 152.1 M. The current year's Enterprise Value is expected to grow to about 128.7 M
Check Genenta Science financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genenta Science's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 324.7 K or Depreciation And Amortization of 44.6 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 6.97. Genenta financial statements analysis is a perfect complement when working with Genenta Science Valuation or Volatility modules.
  
Check out the analysis of Genenta Science Correlation against competitors.

Genenta Science Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets29.6 M22.3 M23.8 M
Slightly volatile
Other Current Liabilities1.1 M1.3 M1.7 M
Slightly volatile
Total Current Liabilities1.6 M1.7 M2.3 M
Slightly volatile
Total Stockholder Equity27.4 M20.4 M21.4 M
Slightly volatile
Other Liabilities140.3 K133.6 K42.5 K
Slightly volatile
Net Tangible Assets13.6 M13.6 M17.4 M
Slightly volatile
Accounts Payable655 K465.9 K585.6 K
Pretty Stable
Cash3.5 M3.7 M19.4 M
Pretty Stable
Non Current Assets Total1.3 M1.1 M920.3 K
Slightly volatile
Non Currrent Assets Other174.4 K183.6 K776.2 K
Very volatile
Cash And Short Term Investments26.7 M18.8 M22 M
Slightly volatile
Net Receivables1.1 M833.7 K665 K
Slightly volatile
Common Stock Shares Outstanding20 M18.2 M18.3 M
Slightly volatile
Liabilities And Stockholders Equity29.6 M22.3 M23.8 M
Slightly volatile
Non Current Liabilities Total188.4 K179.4 K43 K
Slightly volatile
Other Current Assets1.6 M2.5 M699.8 K
Slightly volatile
Total Liabilities1.6 M1.9 M2.3 M
Slightly volatile
Net Invested Capital27.4 M20.4 M21.4 M
Slightly volatile
Total Current Assets28.4 M21.3 M22.8 M
Slightly volatile
Capital Stock44 M67.3 M16.3 M
Slightly volatile
Net Working Capital26.2 M19.5 M20.5 M
Slightly volatile
Common Stock44 M67.3 M16.3 M
Slightly volatile
Property Plant And Equipment Gross85.6 K136.8 K40.4 K
Slightly volatile
Property Plant Equipment15.2 K17.1 K18.6 K
Slightly volatile
Non Current Liabilities Other16.7 K14.6 K25.7 K
Slightly volatile
Intangible Assets48.3 K87.8 K9.2 K
Slightly volatile
Short and Long Term Debt Total11.6713.1314.298
Slightly volatile
Good Will70.2 K78.9 K86 K
Slightly volatile

Genenta Science Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization44.6 K42.5 K30.9 K
Slightly volatile
Interest Expense3.1 M3 M582.1 K
Slightly volatile
Selling General Administrative3.3 M5.3 M1.8 M
Slightly volatile
Other Operating Expenses8.5 M11.7 M5.9 M
Slightly volatile
Research Development5.2 M6.5 M4.1 M
Slightly volatile
Total Operating Expenses8.5 M11.7 M5.9 M
Slightly volatile
Cost Of Revenue43.7 K41.6 K7.7 K
Slightly volatile
Selling And Marketing Expenses4.1 M4.6 M5 M
Slightly volatile

Genenta Science Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation697.3 K739.9 K707.5 K
Slightly volatile
Begin Period Cash Flow24.3 M29.8 M13.7 M
Slightly volatile
Depreciation44.6 K42.5 K7.9 K
Slightly volatile
Other Non Cash Items41.8 K75.7 K18.4 K
Slightly volatile
Capital Expenditures14.7 K13.8 K19.6 K
Slightly volatile
End Period Cash Flow3.5 M3.7 M19.4 M
Pretty Stable
Change To Netincome782.9 K935.1 K756.9 K
Pretty Stable

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
PTB Ratio6.973.99258.2356
Slightly volatile
Book Value Per Share1.11.12171.1536
Slightly volatile
Invested Capital23.7 M26.7 M29.1 M
Slightly volatile
Average Payables448.2 K670.1 K562.4 K
Very volatile
Capex To Depreciation0.310.32498.5146
Slightly volatile
PB Ratio6.973.99258.2356
Slightly volatile
Inventory Turnover0.06310.04790.0615
Slightly volatile
Days Of Inventory On Hand5.3 K7.9 K6 K
Slightly volatile
Payables Turnover0.150.1410.0239
Slightly volatile
Average Inventory62.6 K72.3 K57.9 K
Slightly volatile
Cash Per Share1.071.03071.1833
Pretty Stable
Days Payables Outstanding2.5 K2.6 K90 K
Slightly volatile
Income Quality0.750.96220.6895
Slightly volatile
Tangible Asset Value24.9 M28 M30.5 M
Slightly volatile
Intangibles To Total Assets0.00410.00395.0E-4
Slightly volatile
Net Debt To EBITDA0.30.31582.6874
Pretty Stable
Current Ratio12.2112.246910.8719
Slightly volatile
Tangible Book Value Per Share1.11.11681.1533
Slightly volatile
Graham Number2.474.01672.6593
Slightly volatile
Shareholders Equity Per Share1.11.12171.1536
Slightly volatile
Capex Per Share0.00118.0E-40.0011
Pretty Stable
Graham Net Net0.980.92561.0545
Slightly volatile
Interest Debt Per Share4.0E-46.0E-45.0E-4
Very volatile
Price Book Value Ratio6.973.99258.2356
Slightly volatile
Days Of Payables Outstanding2.5 K2.6 K90 K
Slightly volatile
Ebt Per Ebit1.050.99250.9817
Pretty Stable
Company Equity Multiplier1.211.09371.1258
Pretty Stable
Quick Ratio12.1912.246910.9048
Slightly volatile
Net Income Per E B T0.950.490.9264
Slightly volatile
Cash Ratio2.022.12689.2165
Very volatile
Days Of Inventory Outstanding5.3 K7.9 K6 K
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.11.00121.0096
Slightly volatile
Price To Book Ratio6.973.99258.2356
Slightly volatile
Price Fair Value6.973.99258.2356
Slightly volatile

Genenta Science Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap152.1 M81.6 M162.9 M
Slightly volatile
Enterprise Value128.7 M77.9 M142.2 M
Slightly volatile

Genenta Fundamental Market Drivers

Cash And Short Term Investments18.8 M

Genenta Upcoming Events

24th of April 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View
24th of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Genenta Science Financial Statements

Genenta Science stakeholders use historical fundamental indicators, such as Genenta Science's revenue or net income, to determine how well the company is positioned to perform in the future. Although Genenta Science investors may analyze each financial statement separately, they are all interrelated. For example, changes in Genenta Science's assets and liabilities are reflected in the revenues and expenses on Genenta Science's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Genenta Science SpA. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of Revenue41.6 K43.7 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
RSIRush Street Interactive
OKTAOkta Inc
BACBank of America
When determining whether Genenta Science SpA offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Genenta Science's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Genenta Science Spa Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Genenta Science Spa Stock:
How To Invest In Genenta
Details
Is Genenta Stock a good investment?
Details
What is Genenta Science's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Genenta Science Correlation against competitors.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genenta Science. If investors know Genenta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genenta Science listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.51)
Return On Assets
(0.26)
Return On Equity
(0.43)
The market value of Genenta Science SpA is measured differently than its book value, which is the value of Genenta that is recorded on the company's balance sheet. Investors also form their own opinion of Genenta Science's value that differs from its market value or its book value, called intrinsic value, which is Genenta Science's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genenta Science's market value can be influenced by many factors that don't directly affect Genenta Science's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Genenta Science's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genenta Science is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genenta Science's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY